Skip to main content
MethodsX logoLink to MethodsX
. 2024 Jul 26;13:102878. doi: 10.1016/j.mex.2024.102878

Comparative assessment of three commercial kits and in house optimized PCR assays for GMO screening in food and feed

Daniela Verginelli 1,, Cinzia Quarchioni 1, Katia Spinella 1, Davide La Rocca 1, Pamela Bonini 1, Cristiana Fusco 1, Marisa Misto 1, Stefania Peddis 1, Lorella Peroni 1, Ugo Marchesi 1
PMCID: PMC11345693  PMID: 39188587

Abstract

Screening strategies for GMO detection in food and feed are a crucial aspect in GMO testing laboratories for streamlining the analytical workflow and reducing turnaround time and costs. These strategies can be more or less complex or even be targeted according to the ingredients in the product, but whatever the choice, a good basic approach is generally based on the search for 35S promoter (P35S), nos-terminator (T-nos) and FMV promoter (P-FMV). In this study, we compare the singleplex real time PCR method for P35S, T-nos and P-FMV detection currently adopted by the Italian National Reference Laboratory for GM food and feed (NRL) with three commercial kits available on the market for giving a greater choice to consider the best approach suitable to the official control laboratories that are different from each other.

  • The NRL optimized singleplex PCR methods and the three commercial kits fully respect all the validation parameters criteria according to the minimum performance requirements (MPR) of ENGL [1]

  • Screening strategies for GMO detection in food and feed are a crucial aspect in GMO testing laboratories and being the commercial kits different from each other, the laboratory can choose the methods best suit their needs reducing turnaround time and costs.

Keywords: GMO, Screening elements, In-house verification, Multiplex assay

Method name: Commercial kits and in house optimized PCR assays for GMO screening

Graphical abstract

Image, graphical abstract


Specifications table

Subject area: Biochemistry, Genetics and Molecular Biology
More specific subject area: Real-time PCR, screening assay
Name of your method: Commercial kits and in house optimized PCR assays for GMO screening
Name and reference of original method: Pauli U., Schouwey B., Hubner P., Brodmann P and Eugster A. Quantitative detection of genetically modified soybean and maize: Method evaluation in a Swiss ring trial. 2001. Mitt Lebensm Hyg. 92. 145–158;
UNI EN ISO 21,569 2005/Amd.1:2013(E) Qualitative PCR method for detection of nopaline synthase terminator (QL-ELE-00–011) http://gmo-crl.jrc.ec.europa.eu/gmomethods/docs/QL-ELE-00–011.pdf;
Horizontal methods for molecular biomarker analysis – Methods of analysis for the detection of genetically modified organisms and derived products – Part 5: Real-time PCR based screening method for the detection of the FMV promoter (P-FMV) DNA sequence; ISO/TS 21,569–5:2016 (2016).
Qualitative PCR method for detection of Figwort Mosaic Virus 35S promoter (BLV L 00,00–148, 2014) (QL-ELE-00–015) http://gmo-crl.jrc.ec.europa.eu/gmomethods/docs/QL-ELE-00–015.pdf
Resource availability: Details are provided in method section.

Background

The current European Union (EU) legal framework regulating the presence of genetically modified organisms (GMO) in food and feed on the one hand provides for an unified authorization procedure, on the other imposes mandatory labeling and traceability for food and feed products containing authorized GM events, if more than 0.9 % GM-material is present in any food/feed ingredient (Reg CE 1829/2003 and Reg CE 1830/2003). According to this current legal framework within the EU market, one of the main tasks of GMO testing laboratories in official control is the analytical verification compliance with the labelling and traceability requirements for the presence of authorized genetically modified [2] events in food and feed products. This kind of verification is based on expensive and complex event-specific quantitative methods targeting the more than one hundred currently authorised GM events in addition to the constantly changing number of GM events with a pending/withdrawn authorization in the EU. It is however inconceivable, for logistical and economic reasons, to imagine performing such a large number of quantitative tests on each sample. Actually GMO testing is a complex and stepwise process consisting of consecutive analytical phases adopting PCR modules with increasing levels of specificity. After DNA extraction the first PCR step consists in verifying the presence of the reference gene/es related to the plant species appearing on the product label. Subsequent PCRs are carried out to search for screening elements and, in case of positivity, event-specific PCRs compatible with the screening profiles, and eventual quantifications are performed [[3], [4], [5], [6]]. Whatever the screening strategy adopted, that may differ from laboratory to laboratory, the approach followed by nearly all laboratories in the European Network of GMO Laboratories (ENGL) is the so called “matrix approach” [7], where GM events are matched against the screening elements sought on a table in matrix form showing the theoretical presence/absence of each screening element for each GM event. The analytical results obtained at the screening step on unknown samples can therefore be interpreted according to this matrix so as to rule out from subsequent analytical steps the search for GM events whose presence is incompatible with the obtained screening profile [8].

In the Italian National Reference Laboratory for GM food and feed (NRL) the screening strategy consists of several screening elements (P35S, T-nos, P-FMV, bar, pat, nptII, ctp2-CP4 epsps, TE9) [[9], [10], [11], [12], [13], [14], [15], [16], [17]]. The most common screening elements adopted by enforcement laboratories for revealing the presence of genetically modified organisms (GMO) in food and feed are typically P35S and T-nos. In addition P-FMV provides very useful further information to orientate following analyses. The screening elements are widely present in high number of authorized and unauthorized events, indeed the coverage (in%) on the authorized GM events in the EU including stacked events for P35S is 85.6 %, for T-nos is 83.8 and for P-FMV is 36.2 [18].

Considering how demanding it is for a laboratory to maintain in-house analytical methods under accreditation, for some time now some qualified companies have been offering standardized diagnostic kits for the different stages of GMO analysis, including the screening step. The aim of this study was to assess the technical performances of three commercially available PCR kits (number 1 and 2 are multiplex PCR for the three screening elements, the number 3 is based on duplex PCRs where the detection system for each screening element is coupled with the detection system for the corresponding natural) and internal real time singleplex PCR assays (number 4) routinely used in the laboratory (Table 1).

Table 1.

Overview of Real‐time PCR kits evaluated in the study.

Number Name of kit Manufacturer Real-time PCR assay Target screening elements Internal postive control declared Limit of detection
1 4plex 35S/NOS/FMV/IACa R-Biopharm triplex 35S/NOS/FMV YES ≤ 5 DNA copies
2 GMOScreen RT 35S/NOS/FMV IPCb Eurofins GeneScan triplex 35S/NOS/FMV YES ≤ 10 DNA copies
3 TaqMan™ GMO Screening Kit P35S/TNOS/ P34S-FMVc Thermo Scientific duplex with natural donor 35S/CaMV
NOS/A.Tumefaciens P34S/FMV
YES ≤ 5 DNA copies
4 Internal laboratory method Italian national reference laboratory singleplex P35S
T- nos PFMV
NA ≤ 5 DNA copies

ᵃ35S is detected in FAM channel, NOS in Cy5 channel and FMV in ROX channel.

ᵇ35S is detected in FAM channel, NOS in JOE channel and FMV in TAMRA channel.

ᶜ35S, TNOS, P34S are detected in FAM channel and CaMV, A. tumefaciens, FMV are detected in VIC channel NA means not applicable.

Method details

Experimental design

Twenty-eight samples were analyzed in parallel with three different commercial multiplex real-time PCR test kits for qualitative detection of the three screening elements P35S, T-nos and P-FMV and with the corresponding singleplex assays adopted and accredited by the Italian NRL for GM food and feed. In order to assess the performance of commercial multiplex PCR (mpPCR) qualitative kits, the validation parameters, if already described in the kit validation report, were verified or, if absent, were determined in the laboratory according to the in-house validation procedure (in line with the requirements set out in the ENGL Guidelines) [19]. The experimental design is illustrated in Fig. 1, we briefly described a practical approach for an in-house verification and validation of qualitative multiplex PCR methods. Each performance parameter is determined according to the guidelines reported by Grohmann et al. [19].

Fig. 1.

Fig 1

Schematic workflow representing the experimental design of the study. All samples were extracted in duplicate and analysed in two PCR replicates.

Notes and observations

Several real-time PCR-based screening methods are described and reported in specific method databases (e.g. EURL GMFF GMOMETHODS, EUginius) [18,20] and in scientific literature, including different versions of methods capable of detecting P35S, Tnos and P-FMV [[21], [22], [23]]. In many cases, such screening methods are implemented in their original form, as described in the references, but most of the time these protocols are optimised and adapted by the laboratory to make it possible to perform different tests at the same time in the same working session.

Certified reference materials and real life samples

Twenty-eight real life samples, including processed food matrices containing soy, maize, rice, sugar beet, cotton or flax, were selected. Description and composition of each sample are listed in Table S1. The Certified Reference Materials (CRMs) MON89034 100 % maize (AOCS 0906 E2), T45 100 % canola (AOCS 0208-A), GA21 100 % maize (AOCS 0407-B), MON89788 100 % soybean (AOCS 0906-B), MON40–3–2 10 % soybean (ERM®- BF410ep) were purchased from the American Oil Chemists’ Society (AOCS, Urbana, Illinois, Urbana, USA) or from the European Commission's Joint Research Centre (JRC) and used as positive control samples in the analyses.

Genetically modified screening elements detection methods

Three different commercial kits for GMO screening were assessed (Table 1). Two of them (method 1 and 2) consisted of a single multiplex real-time PCR assay targeting the same screening elements while the third one (method 3) consisted of a proprietary DNA extraction kit associated with three multiplex real-time PCR assays, as detailed below. All three kits have in common that they detect the three most widespread GMO screening elements: P35S, tNOS and P-FMV. Method 1 is a ready-to-use commercial kit (R-Biopharm: SureFood® GMO SCREEN 4plex 35S/NOS/FMV/IAC (Cat. No: S2126)) based on a multiplex assay for a qualitative detection of CaMV P35S, T-nos and P-FMV. Method 2 is another ready-to-use commercial kit (Eurofins GeneScan: GMOScreen RT 35S/NOS/FMV IPC (Cat. No: 5,421,220,301)) where the targets are detected by a real-time PCR multiplex assay. Method 3 is a ready-to-use commercial kit (ThermoScientific: TaqMan™ GMO Screening Kit P35S/TNOS/ P34S-FMV (Cat. No: 4,466,334)) made up of a DNA extraction kit followed by three real-time PCR duplex assays to simultaneously detect each of the three screening targets together with an endogenous sequence of its donor organism: 1) P35S/Cauliflower mosaic virus; 2) T-nos/Agrobacterium tumefaciens; 3) P34S/figwort mosaic virus using three different master mixes. In addition plant DNA as positive Control is amplified. All the commercial kits contain an internal positive control (IPC) to rule out the presence of inhibitors in the sample. The corresponding internal methods (method 4) targeting the three screening elements have long been within the scope of our laboratory's ISO 17,025 accreditation, and regularly used for routine analysis. These assays were optimized experimentally, modifying PCR reagents and, furthermore the PCR performance was assessed as reported by Woll et al. [24]. The qualitative method to detect P35S developed in laboratory, consists in a modified version of that previously described by Pauli et al. [9]: a different forward primer, designed to skip a single nucleotide polymorphism (SNP) affecting the amplification efficiency in the detection of P35S in DAS1507 maize event (DAS-Ø15Ø7–1). This qualitative method was validated by an in house evaluation and a collaborative study as reported by Gatto et al. [10]. The qualitative methods to detect T-nos and P-FMV are derived from the specific European Technical Specification (PD CEN/TS 16,707:2014) suitably modified using a different master mix and a different thermal profile [25]. The verification of PCR performance for the qualitative singleplex assays adopted by the Italian NRL was performed experimentally to assess the equivalence of the real-time PCR reagents used to replace those used in the validated method [26]. Practicability for T-nos and P-FMV has been checked on soybean MON40–3–2 10 % (ERM®- BF410ep) and maize MON89034 100 % (AOCS 0906 E2) using the master mix for the original validation QuantiTect Multiplex PCR NoROX Kit (Qiagen Gmbh, Germany) and the alternative master mix 1X TaqMan Universal Master Mix (Applied Biosystems, Foster City, CA).

Notes and observations

To further reduce the analytical workload, a number of commercial suppliers have started offering basic GMO screening kits that can detect the previously mentioned three elements. This can actually be an excellent alternative as long as the kit has comparable performance to the original methods. To verify the adoptability of these alternative solutions in the present study, three commercial kits, together with the corresponding internal methods already accredited by the testing laboratory, were verified in-house and, where necessary, additional validation parameters were determined, for the detection of P35S, Tnos and P-FMV on twenty-eight real life samples containing different ingredients. The performance parameters taken into account according to the ENGL guidelines [18] were Specificity, Absolut Limit of detection (LODabs), Asymmetric LOD (LODasym) and Cross-talk. The R-Biopharm (method 1) and Eurofins GenScan (method 2) mpPCR qualitative assays tested were designed from the providers in order to detect simultaneously P35S, T-nos and P-FMV in three different fluorescence channels. Differently, Thermo Fisher ScientificThermofisher’ kit (method 3) proposes an alternative approach for finding the three screening targets on the basis of the following considerations. Since the 35S promoter is originally derived from the Cauliflower Mosaic Virus (CaMV), the NOS terminator from tumour-inducing (Ti) plasmids of Agrobacterium tumefaciens and the FMV promoter from the figwort virus, these regulatory elements, if detected in the sample, could derive from a natural infection of the plants used for the preparation of the analysed foodstuff.

To reduce the chance of false positive results from these naturally occurring microbes, Thermo Fisher Scientific kit was designed as three duplex PCR assays, each of which detecting the GM element (P35S or T-nos or P-FMV) and the corresponding genomic sequence specific for its donor organism (Cauliflower mosaic virus, A. tumefaciens and figwort virus).

The internal laboratory assays (method 4), derived from already published methods detecting the screening elements considered in this study, have been further optimised to make their experimental conditions compatible with those already in use for other methods employed in the laboratory's diagnostic routine (e.g. using the same master mix and thus the same amplification profile). The singleplex assay for P35S was validated in a collaborative study involving 17 laboratories 10, while the T-nos and P-FMV assays were verified experimentally in order to assess the equivalence of real-time PCR reagent used. In addition, the three methods have a long history of accreditation at the national reference laboratory that conducted the tests in this study.

DNA extraction

For all tests performed in this study, with the exception of ThermoScientific TaqMan™ GMO Screening Kit, DNA extraction was carried out in two replicates from 2 g of real life samples and 200 mg of certified Reference Material (CRM) used as positive control with the exception of CRM soybean MON89788 and CRM soybean MON40–3–2 where the intake had to be reduced down to 150 mg to help resuspension in lysis buffer. ION-Force DNA extractor FAST (©Generon S.p.A, Italy), CTAB method with minor modifications on buffer volume and, RSC PureFood GMO performed DNA extraction by using Maxwell®RSC Instrument (Promega Madison, WI, USA) as nucleic acid purification platform, according to the manufacturer's instructions. For testing with ThermoScientific: TaqMan™ GMO Screening Kit, upon specific request of the supplier, DNA was extracted by GMO Extraction Kit Thermo Scientific™ (Thermo Fisher Scientific Waltham, MA, USA), from 10 g of material according to the manufacturer's instructions.

DNA yield and quality assessment

Concentration and purity of the extracted DNA were evaluated by spectrophotometric measurements (Eppendorf, Hamburg, DE) at 260 nm and 260/280 ratio according to the ISO 21,570:2005, Annex B [6] (on single stranded DNA) and following the instrument's operating manual.

Real-time PCR assays

Real-Time PCR was performed on the QuantStudio7 (Life Technologies, Foster City, CA, USA) in a final volume of 25 μl with 100 ng of template DNA, using 1X TaqMan Universal Master Mix (Applied Biosystems, Foster City, CA). The thermal profile used for PCR reactions was: UNG pre-treatment of 2 min at 50 °C, initial activation of the polymerase for 10 min at 95 °C followed by 50 cycles of 95 °C for 15 s and 60 °C for 60 s. The baseline and the fluorescence threshold were automatically set up by the instrument software. Each commercial kit was used according to the manufacturer's instructions. References of the Italian NRL methods are indicated in the Table 2. The primes and probes for real time PCR were supplied by Eurofins genomics (Ebersberg, Germany).

Table 2.

Italian NRL methods.

Gene name, primers and probes final concentration reference
p35S (84bp amplicon) Gatto F and Paternò A, Report of the collaborative study for the validation of real time PCR methods for GMO screening, IZSLT, 2011 (Pauli et al., modified) https://www.izslt.it/crogm/pubblicazioni/ Pauli et al., “Quantitative detection of genetically modified soybean and maize: Method evaluation in a Swiss ring trial” (2001). Mitt. Lebensm. Hyg. vol. 92/2: 145–158
35S-F3 0.4 pmol/μl
35S-R 0.4 pmol/μl
35S-TMP 0.2 pmol/μl
tNOS (84bp amplicon) UNI EN ISO 21,569 2005/Amd.1:2013(E) Qualitative PCR method for detection of nopaline synthase terminator (GMOMETHODS: QL-ELE-00–011)
180 F 0.4 pmol/μl
180 R 0.4 pmol/μl
Tm-180 0.1 pmol/μl
pFMV (78bp amplicon) ISO/TS 21,569–5:2016(E) (GMOMETHODS: QL-ELE-00–015)
pFMV-F 0.34 pmol/μl
pFMV-R 0.34 pmol/μl
Probe pFMV 0.12 pmol/μl
LECTIN (LEC) GENE (74bp amplicon) GMOMETHODS: QT-TAX-GM-002
Lec-F 0.3 pmol/μl
Lec-R 0.3 pmol/μl
Lec-P 0.1 pmol/μl
HIGH-MOBILITY-GROUP (HMG) GENE (79bp amplicon) GMOMETHODS: QTTAX-ZM-002
MaiJ-F2 0.30 pmol/μl
mhmg-rev 0.30 pmol/μl
Mhmg-probe 0.18 pmol/μl
FIBER-SPECIFIC ACYL CARRIER PROTEIN (ACP1) GENE (76bp amplicon) GMOMETHODS: QT-TAX-GH-015
Acp1-F 0.15 pmol/μl
Acp1-R 0.15 pmol/μl
Acp1-P 0.05 pmol/μl
PHOSPHOLIPASE D (PLD) GENE (64bp amplicon) GMOMETHODS: QT-TAX-OS-017
KVM159 0.2 pmol/μl
KVM160 0.2 pmol/μl
TM013 probe 0.2 pmol/μl
GLUTAMINE SYNTHETASE (GS) GENE (121bp amplicon) GMOMETHODS: QT-TAX-BV-013
GLUA3-F 0.15 pmol/μl
GLUA3-R 0.15 pmol/μl
GLUD1-probe 0.1 pmol/μl

PCR inhibition test

The absence of PCR inhibitors in the DNA samples were evaluated according to the Annex 2 “Verification of analytical methods for GMO testing when implementing interlaboratory validated methods” JRC reported by Hougs et al., 2017 [26].

The inhibition test was performed in two dilution points of the taxon-specific reference systems. The amplification was performed in a final volume of 25 µl for the determination of quantification cycle (Cq) values at the two dilution levels (40 ng/ul and 10 ng/ul or undiluted and diluted 1:4) in two replicates of PCR. The difference between the measured Cq and the expected Cq was evaluated (ΔCq), considering the sample inhibited when ΔCq < 1.5 (Tab. S1).

Specificity

The experimental specificity for all the qualitative methods was evaluated by the Italian NRL according to the Definition of Minimum Performance Requirements for Analytical Methods of GMO Testing part 2 JRC [1].The acceptance criterion used for the specificity parameter is that the PCR system developed should only produce amplification for the organisms for which the amplicon is expected to be detected. The experimental specificity was already evaluated by all the commercial kit providers and by the Italian NRL, several CRMs containing P35S and/or T-nos and/or P-FMV were tested. This parameter for the commercial kit Eurofins (method 2) was evaluated by the provider also in silico using BLAST. In this study, to investigate the capacity of a method to detect only the target analyte and discriminate all other targets we selected, and tested in duplicate, real life samples containing all, some, or no targets.

Absolute lod verification

The determination of sensitivity was assessed measuring the limits of detection (LOD) defined as the lowest amount or concentration of analyte in a sample, which can be reliably detected, but not necessarily quantified. In the event that the LODabs was already determined and reported in the context of each method validation, the ENGL guidance document on multiplex PCR optionally suggests an intralaboratory verification [19]. Such verification was carried out by testing 10 PCR replicates at four serial dilutions contained approximately 20, 10, 5 and 1 copies/reaction of each target with the requirement to obtain amplification for all ten replicates. The LOD is considered the lowest copy number for which the ten PCRs are positive 20. The values were verified by using Quodata web application too (https://quodata.de/content/validation-qualitative-pcr-methods-single-laboratory/520fd1e35f2d601a4a96c7da9ddf4acc41a49000ad0c0166a2b580394b6443b2b41dba5d77c8776213c446b24b3477eed322f459984b808824d758e903002c7a253).

In addition for the method Eurofins (method 2) the LODabs is carried out with the verification kit for qualitative PCR Kit (Verification kit for qualitative PCR kits, ID2936) according to the manufacturer's instructions (data no shown).

Asymmetric LOD determination

The LODasym is the lowest amount of an analyte in a sample that can be reliably detected, but not necessarily quantified, in the presence of high amount(s) of other target(s) in the multiplex PCR (mpPCR) assay [18]. All PCR replicates should provide positive results at LODasym conditions. For R-Biopharm kit (method 1) this performance parameter was estimated from scratch, as it was not included in the validation report of the supplier. For Eurofins GeneScan kit (method 2) an experimental verification of the data reported by the supplier was sufficient. Finally, for Thermofisher methods (method 3) and the NRL internal methods (method 4) this check was not applicable.

The concentration of DNA was checked by droplet digital PCR (ddPCR) as recommended by Grohman et al. [18] (data not shown). The verification of the LODasym for Eurofins GeneScan’ kit (method 2) was assessed in 10 PCR replicates for each target with 10 target copies/reaction in the presence of 5000 copies/reaction of all other targets (ratio 1/500).

The estimation of the LODasym for R-Biopharm (method 1) of each module is established by means of serial dilutions made from mixtures of the target DNA in excess of the other targets. Twelve PCR replicates at 20 copies/reaction of each target in the presence of 5000 copies/reaction of all other targets (ratio 1/250) were tested for each screening element. In the case of P35S and T-nos one or more PCR replicates were negative therefore twelve PCR replicates at 20 copies/reaction of P35S in the presence of 3000 copies/reaction of all other targets (ratio 1/150) and 25 copies/reaction of Tnos in the presence of 3000 copies/reaction of all other targets (ratio 1/120) were tested [19].

The CRMs T45 100 % canola (AOCS 0208-A) for P35S, GA21 100 % maize (AOCS 0407-B) for T-nos and MON89788 100 % soybean (AOCS 0906-B) for P-FMV were used as positive controls.

In addition for the method Eurofins (method 2) the LODasym is carried out with the verification kit for qualitative PCR Kit (Verification kit for qualitative PCR kits, ID2936) according to the manufacturer's instructions (data not shown).

Crosstalk

The fluorescence signals generated during the amplification of different targets may bleed through between adjacent detection channels and superimpose each other and this may fake target sequence amplifications, resulting in false positives [19]. The experimental design of the cross-talk test is conducted in absence of the target and in 20.000 copies number for the other PCR module(s) in the respective channel(s) in three replicates per testing condition. The CRMs canola T45 100 % (AOCS 0208-A) for P35S; maize GA21 100 % (AOCS 0407-B) for t-NOS; soybean MON89788 100 % (AOCS 0906-B) for P-FMV were used as positive control. Acceptance Criteria: no cross-talk should be detected.

DNA yield and quality assessment

The presence of inhibitors were investigated and the DNA extracted from 28 real life samples with different methods resulted no inhibited (Tab. S1). The DNA purity based on the average absorbance ratio 260/280 nm was close to the optimum value of 1.8 for almost all of samples. Samples analysed with the ThermoScientific GMO Screening kit (method 3) and extracted using the specific kit (GMO Extraction Kit Thermo Scientific) provided by Thermofisher, showed a lower DNA yield (sometimes <40 ng/ul) and a lower Cq of endogenous gene compared to other extraction kits.

Experimental specificity

The Cq values obtained by testing 16 target and 12 non-target samples are summarized in Table 3A. The specificity was assessed measuring the number of false positive and the number of false negative samples (Table 3B). On the whole the verified results obtained for the detected screening elements are in accordance with the expected results. In only two expected negative samples weak signal (>38 Cq) were detected in one of the two PCR replicates.

Table 3A.

Specificity test for the multiplex real-time PCR assay and NRL' assays.

Verified
P35S
T-nos
P-FMV
Number samples Real life samples GM event detected Screening element expected R-Biopharm Eurofins GeneScan Thermo Fisher NRL R-Biopharm Eurofins GeneScan Thermo Fisher NRL R-Biopharm Eurofins GeneScan Thermo Fisher NRL
1 soybean flour (GM soy labelled) MON40–3–2, MON87701, MON89788 P35S, T-nos, P-FMV 25.83±0.06 26.17±0.10 21.51±0.13 27.42±0.10 24.85±0.01 26.95±0.01 22.47±0.09 27.36±0.06 26.40±0.04 29.98±0.41 22.93±0.1 27.24±0.08
2 soybean flour (GM soy labelled) MON40–3–2, MON87701, MON89789 P35S, T-nos, P-FMV 25.82±0.22 25.58±0.18 21.09±0.01 27.38±0.10 24.79±0.11 26.49±0.15 21.93±0.13 27.06±0.13 26.81±0.00 29.38±0.01 22.91±0.001 27.48±0.17
3 soybean meal (GM soy labelled) A5547–127, A2704, MON40–3–2, MON87708, MON89788 P35S, T-nos, P-FMV 27.70±0.10 27.37±0.19 23.37±0.024 28.98±0.05 27.32±0.09 29.94±0.40 26.41±0.29 31.19±0.007 25.69±0.06 27.79±0.26 22.28±0.004 26.13±0.03
4 feed (GM soy and maize labelled; cotton) GM soy and maize labelled, MON87460 spiked sample P35S, T-nos, P-FMV 25.19±0.14 25.09±0.03 25.57±0.13 25.4 ± 0.14 24.34±0.09 26.04±0.13 26.38±0.02 29.25±0.07 25.55±0.12 28.29±0.32 25.76±0.22 26.24±0.19
5 feed (GM soy labelled; maize) DAS1507, GA21, MON89034, NK603, MIR162, MON810, MON88017, BT11 P35S, T-nos, P-FMV 25.48±0.25 25.82±0.18 28.97±0.003 29.65±0.21 24.23±0.22 26.43±0.17 30±0.04 32.85±0.07 25.87±0.14 29.22±0.32 25.91±0.08 26.50±0.79
6 feed (GM soy and maize labelled; flax) GM soybean and maize labelled P35S, T-nos, P-FMV 26.15±0.15 28.95±0.06 28.67±0.12 29.15±0.07 27.29±0.13 30.30±0.22 30.54±0.22 32.85±0.07 24.58±0.23 28.72±0.41 26.55±0.07 28.27±0.14
7 feed (GM soy and maize labelled; cotton; sugarbeet) GM soybean and maize labelled P35S, T-nos, P-FMV 27.16±0.30 26.52±0.07 28.92±0.29 27.85±0.21 27.68±0.28 27.50±0.13 29.95±0.4 30.1 ± 0.00 25.52±0.25 34.10±1.63 27.82±0.26 27.56±0.21
8 dehulled soy meal (GM soy labelled) A2704, MON40–3–2, MON87708, MON89788 P35S, T-nos, P-FMV 26.93±0.15 27.69±0.09 22.86±0.09 29.015±0.09 27.87±0.11 29.71±0.12 25.11±0.001 30.59±0.007 25.30±0.01 28.61±0.05 22.33±0.03 27.56±0.21
9 dehulled soy meal (GM soy labelled) A2704, MON40–3–2, MON87708, MON89789, DP305423 P35S, T-nos, P-FMV 26.28±0.06 27.08±0.23 25.83±0.26 27.45±0.07 27.50±0.10 29.26±0.013 26.74±0.41 30.7 ± 0.14 25.40±0.01 28.39±0.01 25.56±0.32 26.74±0.71
10 soy meal (GM labelled) MON40–3–2, MON87708, MON89788 P35S, T-nos, P-FMV 25.91±0.86 26.79±0.25 21.84±0.2 27.86±0.007 26.55±0.60 27.64±0.15 22.56±0.31 28.13±0.05 26.61±0.67 29.63±0.18 23.71±0.16 28.37±0.22
11 maize flour (raw material) MON40–3–2, MON87708, MON89789 P35S, T-nos, P-FMV 24.08±0.29 27.55±0.02 30.08±0.19 30.95±0.77 25.83±0.05 28.43±0.11 31.36±0.16 31.9 ± 0.5 25.22±0.02 29.38±0.13 26.24±0.07 25.44±0.19
12 polenta (maize) Spiked sample Bt176 P35S 30.20±0.29 31.87±0.45 38.64±0.08 32.06±0.08 ND ND ND ND ND ND ND ND
13 feed (GM soy and maize labelled; cotton; flax) GM soybean and maize labelled P35S, T-nos, P-FMV 26.91±0.01 28.93±0.15 27.84±0.24 26.75±0.21 27.92±0.03 29.88±0.26 29.02±0.01 29.15±0.35 27.37±0.14 33.47±0.22 27.6 ± 0.03 27.09±0.07
14 cracked corn (GM maize labelled) MON810, MON89034, NK603 P35S, T-nos, P-FMV 28.74±0.28 31.04±0.02 28.19±0.85 31.31±0.021 30.71±0.14 32.33±0.26 28.46±1.01 31.7 ± 0.3 29.33±0.02 34.93±0.21 29.63±0.9 31.61±0.48
15 corn for popcorn MON89034 NQ, NK603 NQ P35S, T-nos, P-FMV 30.07±0.16 32.26±0.27 32.76±0.16 34.53±0.59 33.76±0.16 34.69±0.18 32.77±0.005 36.64±0.37 34.59±0.04 36.36±1.37 33.95±0.11 35.59±0.38
16 feed (GM soy and maize labelled, sugarbeet) GM soybean and maize labelled P35S, T-nos, P-FMV 23.47±0.02 26.44±0.34 27.55±0.001 27.75±0.21 25.18±0.10 27.63±0.18 28.89±0.06 29.3 ± 0.14 23.40±0.19 25.21±0.38 27.18±0.06 27.33±0.24
17 feed (soy) not tested Negative ND ND ND ND ND ND1 ND ND ND ND ND ND
18 corn for popcorn not tested Negative ND ND ND ND ND ND ND ND ND ND ND ND
19 maize flour not tested Negative ND ND ND ND ND ND ND ND ND ND ND ND
20 maize flour not tested Negative ND ND ND ND ND ND ND ND ND ND ND ND
21 soybean flour not tested Negative ND ND ND ND ND ND ND ND ND ND ND ND
22 feed (maize, soy) not tested Negative ND ND ND ND ND ND ND ND ND1 ND ND ND
23 rice flour not tested Negative ND ND ND ND ND ND ND ND ND ND ND ND
24 feed (maize, rice) not tested Negative ND ND ND ND ND ND ND ND ND ND ND ND
25 biscuits (soy) not tested Negative ND ND ND ND ND ND ND ND ND ND ND ND
26 rice cream not tested Negative ND ND ND ND ND ND ND ND ND ND ND ND
27 maize flour not tested Negative ND ND ND ND ND ND ND ND ND ND ND ND
28 maize flour not tested Negative ND ND ND ND ND ND ND ND ND ND ND ND
POS CTR positive control kit NA P35S, T-nos, P-FMV 27.01 31.04 31.61 NA 25.47 31.91 32.38 NA 28.46 32.9 31.8 NA
POS CTR positive control NRL (MON89034 100 % GM, AOCS 0906-E) MON89034 P35S, T-nos, P-FMV 25.73 26.53 23.47 24.24 26.74 27.39 23.63 25.32 27.33 28.4 23.14 21.95

NTC NTC NA Blank ND ND ND ND ND ND ND ND ND ND ND ND

For positive amplification signals, Cq mean value and standard deviation are indicated; NQ means not quantified (<LOQ), ND means not detected, NA means not applicable.

1

undetermined and Cq ≥38.

Table 3B.

number of false positive samples and false negative samples obtained in the study.

Verified
R-Biopharm
Eurofins GeneScan
Thermofisher
NRL
Target Expected False positive samples False negative samples False positive samples False negative samples False positive samples False negative samples False positive samples False negative samples
P35S Positive 16 0 0 0 0 0 0 0 0
Negative 12
T-nos Positive 15 0 0 0 0 0 0 0 0
Negative 13
PFMV Positive 15 0 0 0 0 0 0 0 0
Negative 13

Notes and observation

The in-house verification data presented here show that all three multiplex real-time PCR assays and singleplex assays are fit for purpose for the reliable detection of GM food and feed. The specificity was evaluated in twenty-eight real life samples including matrices that are relevant for a testing laboratory e.g. soybean, maize, cotton, rice and sugar beet with different degree of processing as highly processed matrices such as biscuits and polenta, in order to have a wide range of the applicability in routine testing of these qualitative assays. To confirm the results, CRMs were used as positive controls.

The overall assessment of the commercial screening systems considered in this paper is rather favorable in terms of both applicability and practicability. The targets chosen are those most popular with GMO testing laboratories and the multiplex kit format facilitates the operator's work and reduces processing time.

Regarding specificity the results showed that all PCR methods performed appropriately in detecting the screening targets in all the samples (just for two PCR replicates a weak signal above 38 Cq was detected).

Verification of absolute LOD

LODabs was verified for all methods tested. For each PCR method tested, an amplification signal was detected for all ten replicates at 5 target copies. The observed result was the same as expected for all methods (Table 4). Quodata elaborations confirmed the obtained results (Fig.S1).

Table 4.

Estimation of the absolute limit of detection (LODabs). The CRM used was MON89034 100 % maize (AOCS 0906-E2); NA means not ampliflied.

R-Biopharm (Method 1) declared LOD: 5 gen copies
Cq
Cq
Cq
GM copies number 20 10 5 1 GM copies number 20 10 5 1 GM copies number 20 10 5 1

LODabs P35S (FAM) 31.53 30.76 30.20 NA LODabs T-nos (Cy5) 30.36 32.21 31.03 NA LODabs PFMV (ROX) 29.62 30.55 30.88 NA
29.95 29.65 30.80 NA 30.10 31.42 33.26 NA 29.13 30.78 30.52 NA
30.28 30.54 30.99 38.06 30.85 30.92 32.93 NA 29.46 30.00 31.71 32.90
29.38 29.24 29.99 NA 30.08 31.37 31.56 NA 29.30 30.97 31.28 32.77
29.74 30.44 29.80 35.94 29.85 31.94 31.43 NA 28.89 30.76 29.95 NA
29.09 29.68 29.62 34.66 30.77 32.10 31.97 NA 29.27 30.32 30.50 NA
29.48 29.81 31.34 NA 30.60 30.10 32.74 NA 29.11 29.80 31.44 32.56
29.12 29.60 29.10 NA 30.10 31.61 31.97 NA 29.20 29.65 30.58 NA
29.17 29.52 30.15 NA 30.42 31.02 30.85 NA 29.34 29.74 30.75 NA
28.92 29.29 29.07 35.68 29.84 30.79 34.62 32.23 29.72 29.69 31.03 NA
positive n. 10 10 10 4 positive n. 10 10 10 1 positive n. 10 10 10 3
% 100 100 100 40 % 100 100 100 10 % 100 100 100 30
Eurofins GeneScan (Method 2) declared LOD: 10 gen copies
Cq
Cq
Cq
GM copies number 20 10 5 1 GM copies number 20 10 5 1 GM copies number 20 10 5 1

LODabs P35S (FAM) 34.65 35.33 34.62 39.13 LODabs T-nos (JOE) 35.18 36.12 35.44 NA LODabs PFMV (TAMRA) 34.57 35.66 36.32 NA
33.96 34.84 35.39 38.55 34.56 35.13 36.88 40.66 34.66 35.38 36.94 NA
33.71 35.12 35.62 38.56 34.94 35.72 36.82 38.82 34.35 35.79 36.96 36.98
34.07 34.55 35.48 43.91 33.90 35.59 35.78 37.80 34.48 35.07 36.56 38.52
34.54 35.48 34.98 NA 33.92 35.23 35.44 37.20 34.26 35.18 34.87 NA
33.73 34.77 35.21 37.37 33.74 35.94 37.54 NA 34.06 35.02 36.07 NA
33.55 34.99 36.78 NA 34.60 35.28 37.85 NA 34.54 34.99 37.11 38.29
33.95 34.16 36.96 NA 35.27 35.67 36.89 NA 34.37 35.36 38.05 37.54
34.07 35.04 35.85 NA 34.07 35.00 36.19 NA 34.62 35.51 36.31 NA
33.86 34.31 35.67 NA 33.90 35.06 35.80 38.67 34.30 35.57 36.94 39.25
n. pos 10 10 10 5 n. pos 10 10 10 5 n. pos 10 10 10 5
% 100 100 100 50 % 100 100 100 50 % 100 100 100 50
ThermoScientific (Method 3) declared LOD: 5 gen copies
Cq
Cq
Cq
GM copies number 20 10 5 1 GM copies number 20 10 5 1 GM copies number 20 10 5 1

LODabs P35S (FAM) 34.66 35.56 36.52 39.02 LODabs T-nos (FAM) 32.81 33.32 34.17 NA LODabs PFMV (FAM) 35.38 35.77 38.69 39.27
35.46 35.30 36.64 40.08 32.64 33.74 34.85 NA 35.11 36.59 37.99 NA
35.16 35.24 38.28 38.12 32.43 33.26 36.13 NA 35.03 37.23 37.43 39.70
34.65 35.93 36.55 39.03 32.64 33.93 36.03 NA 35.08 37.05 36.40 38.22
34.67 35.05 36.51 NA 32.24 33.81 34.52 36.44 34.98 36.60 37.40 39.19
34.58 35.39 35.79 38.98 33.03 33.67 34.99 35.33 34.56 36.15 37.58 39.02
34.69 35.35 37.41 38.18 33.85 33.98 34.78 NA 34.99 36.31 38.64 39.32
34.37 35.38 37.06 38.19 33.15 33.87 34.66 38.53 35.98 36.42 37.36 39.14
34.72 36.32 37.98 38.74 32.62 33.55 34.98 36.16 35.62 35.89 37.41 38.41
34.62 35.94 36.53 37.80 33.17 33.30 35.17 35.63 37.00 36.61 38.55 39.27
n. pos 10 10 10 9 n. pos 10 10 10 5 n. pos 10 10 10 9
% 100 100 100 90 % 100 100 100 50 % 100 100 100 90
Italian NRL methods (Method 4) LOD P35S; T-nos; PFMV: 5 cp
Cq
Cq
Cq
GM copies number 20 10 5 1 GM copies number 20 10 5 1 GM copies number 20 10 5 1

LODabs P35S (FAM) 34.98 35.12 35.99 37.75 LODabs T-nos (FAM) 34.85 35.57 36.81 39.68 LODabs PFMV (FAM) 33.42 34.12 37.79 38.31
33.99 35.13 36.60 38.69 34.30 36.88 36.89 38.13 33.62 34.88 34.89 35.82
34.02 35.33 37.82 NA 35.26 36.28 37.21 NA 33.16 34.52 36.16 38.91
34.03 35.50 36.89 37.53 35.22 36.80 38.50 39.87 33.60 34.80 37.74 37.57
34.05 34.98 36.22 NA 34.80 36.18 36.89 NA 33.19 35.12 35.15 36.58
33.87 36.09 36.78 38.63 35.24 37.72 36.36 NA 33.35 35.41 35.84 NA
33.91 36.08 35.95 39.03 34.84 35.90 36.22 NA 33.97 35.45 35.74 37.39
33.79 35.41 35.30 37.56 34.97 35.85 38.08 40.60 33.96 34.57 35.97 37.56
34.06 34.65 37.33 38.64 34.80 36.50 38.97 37.87 34.14 35.17 36.82 36.89
34.14 34.79 35.97 NA 35.35 35.36 37.53 37.77 33.64 34.95 35.34 38.69
n. pos 10 10 10 7 n. pos 10 10 10 6 n. pos 10 10 10 9
% 100 100 100 70 % 100 100 100 60 % 100 100 100 90
LOD95 % values verified by using Quodata web application
Screening kit LOD
P35S T-NOS PFMV

R-Biopharm (Method 1) 4.42 6.72 5.15
Eurofins GeneScan (Method 2) 3.73 3.73 3.73
ThermoScientific (Method 3) 1.3 3.73 1.3
Italian NRL methods (Method 4) 2.44 3.06 1.3

Notes and observation

Although absolute limit of detection (LODabs) is indicated as optional in the “Guidance document on multiplex real-time PCR methods” [19] for the validation and verification of mpPCR this parameter were evaluated as well. The LODabs of the different commercial systems in multiplex format resulted having a perfect match with the three singleplex assays adopted by NRL (5 copies for all targets).

Estimation of asymmetric LOD

The LODasym was determined per each target in presence of high amounts of the other targets as described by Grohmann et al. [19]. For R-Biopharm kit (method 1) a positive signal was detected for all twelve replicates with 20 copies of P-35S in a background of 3000 copies (1/150), 25 copies of Tnos in a background of 3000 copies (1/120) and 20 copies of P-FMV in a background of 5000 copies (1/250). For EurofinsGenScan (method 2) the LODasym verification a positive signal was detected in all ten replicates at 10 target copies in a background of 5000 non-target copies (1/500) (Table 5).

Table 5.

Estimation of the asymmetric limit of detection (LODasym). Positive control used were T45 100 % canola (AOCS 0208-A) for p35S; GA21 100 % maize (AOCS 0407-B) for tNOS and MON89788 100 % soybean (AOCS 0906-B) for pFMV.

R-Biopharm (Method 1)
DETERMINATION OF LODasym R-Biopharm
LODasym p35S (FAM)
20 copies / 1500 copies + 1500 copies (1/150)
LODasym tNOS (Cy5)
25 copies / 1500 copies + 1500 copies (1/120)
LODasym pFMV (ROX)
20 copies / 2500 copies + 2500 copies (1/250)
Cq
20 copies T45 (p35S)
Cq Background
1500 copies
GA21 (tNOS)
Cq Background
1500 copies
MON89788 (pFMV)
Cq
25 copies GA21 (tNOS)
Cq Background
1500 copies
T45 (p35S)
Cq Background
1500 copies MON89788 (pFMV)
Cq
20 copies MON89788 (pFMV)
Cq Background
2500 copies
T45 (p35S)
Cq Background
2500 copies
GA21 (tNOS)
33.46 26.86 26.90 32.62 27.05 26.56 30.08 25.26 30.35
35.75 26.61 26.70 32.76 27.08 26.60 30.37 25.40 30.70
33.88 26.51 26.51 31.75 26.99 26.56 30.66 25.34 30.97
32.76 26.51 26.55 32.69 26.90 26.47 31.33 25.08 31.79
35.29 26.42 26.39 36.13 26.60 26.46 30.24 25.09 30.61
34.22 26.60 26.57 32.20 26.89 26.37 30.37 25.06 30.73
36.45 26.64 26.48 31.13 26.67 26.42 31.01 25.08 31.52
33.80 26.36 26.44 31.95 26.84 26.41 30.52 24.95 30.91
33.14 26.75 26.35 36.58 26.97 26.51 30.58 25.22 30.94
38.90 26.54 26.58 34.52 26.84 26.47 30.53 25.10 30.89
35.17 26.44 26.49 32.95 26.75 26.45 30.27 25.16 30.61
34.58 26.55 26.53 34.31 27.15 26.91 31.06 25.31 31.55
Eurofins-GeneScan (Method 2)

VERIFICATION OF LODasym Eurofins

LODasym p35S (FAM) 10 copies / 2500 copies + 2500 copies (1/500)
LODasym tNOS (JOE) 10 copies / 2500 copies + 2500 copies (1/500)
LODasym pFMV (TAMRA) 10 copies / 2500 copies + 2500 copies (1/500)
Cq 10 copies T45 (p35S) Cq Background 2500 copies GA21 (tNOS) Cq Background 2500 copies MON89788 (pFMV) Cq 10 copies GA21 (tNOS) Cq Background 2500 copies
T45 (p35S)
Cq Background 2500 copies MON89788 (pFMV) Cq 10 copies MON89788 (pFMV) Cq Background 2500 copies
T45 (p35S)
Cq Background 2500 copies
GA21 (tNOS)

34.53 26.54 27.62 33.43 26.85 27.37 35.79 26.85 26.48
33.87 26.56 27.61 33.88 26.58 26.99 36.23 26.71 26.47
34.96 26.39 27.28 33.30 26.65 27.07 35.66 26.71 26.24
35.29 26.33 27.46 33.45 26.45 27.18 35.52 26.67 26.17
34.66 26.23 27.30 33.54 26.40 26.95 33.90 26.39 26.16
33.98 26.33 26.81 34.38 26.47 26.77 35.04 26.40 26.18
34.92 26.32 27.09 33.92 26.37 26.98 34.91 26.77 26.39
33.85 26.39 27.25 33.63 26.39 26.75 35.60 26.62 26.25
33.66 26.27 27.17 33.99 26.46 27.14 34.47 26.56 26.25
34.49 26.24 27.32 34.04 26.51 27.32 35.20 26.48 26.28

Notes and observation

Asymmetric LOD (LODasym) was obviously considered for mpPCR systems only. This parameter showed a better performance for Eurofins GeneScan kit (method 2) than for R-Biopharm kit (method 1). This could have potential effects in the case of very unbalanced presence in the sample of the three screenings elements, however in the real life samples analysed in this study no differences could be detected.

Crosstalk

Cross-talk evaluation was carried out for 3 PCR replicates as described in Method details. The R-Biopharm and Eurofins Gene scan kits did not cross-react and had no influence on sensitivity since no interfering fluorescence signals were found in the multiplex PCR tests (Table 6).

Table 6.

Evaluation of cross-talk signals. Positive control used were T45 100 % canola (AOCS 0208-A) for P35S; GA21 100 % maize (AOCS 0407-B) for tNOS; MON89788 100 % soybean (AOCS 0906-B) for PFMV.

CROSS-TALK R-Biopharm (method 1)
CROSS-TALK Eurofins GeneScan (method 2)
P35S (FAM)
P35S (FAM)
Cq
0 copies/reaction
T45 (P35S)
Cq
20,000 copies/reaction
GA21 (t-NOS)
Cq
20,000 copies/reaction
MON89788 (PFMV)
Cq
IPC (VIC)
Cq
0 copies/reaction
T45 (P35S)
Cq
20,000 copies/reaction
GA21 (t-NOS)
Cq
20,000 copies/reaction
MON89788 (PFMV)
Cq
IPC (Cy5)
Undetermined 22.95 22.71 27.32 Undetermined 23.14 25.33 33.87
Undetermined 22.73 22.59 28.35 Undetermined 23.08 24.87 33.26
Undetermined 22.65 22.49 27.82 Undetermined 22.98 24.9 32.77

t-NOS (Cy5) t-NOS (JOE)

Cq
0 copies/reaction
GA21(t-NOS)
Cq
20,000 copies/reaction
T45 (P35S)
Cq
20,000 copies/reaction
MON89788 (PFMV)
Cq
IPC (VIC)
Cq
0 copies/reaction
GA21
(t-NOS)
Cq
20,000 copies/reaction
T45 (P35S)
Cq
20,000 copies/reaction
MON89788 (PFMV)
Cq
IPC (Cy5)
Undetermined 23.12 23.04 25.82 Undetermined 23.92 24.95 33.47
Undetermined 22.97 22.94 26.72 Undetermined 23.64 24.73 33.59
Undetermined 22.97 22.94 25.62 Undetermined 23.7 24.59 32.72

PFMV (ROX) PFMV (TAMRA)

Cq
0 copies/reaction
MON89788
(PFMV)
Cq
20,000 copies/reaction
T45 (P35S)
Cq
20,000 copies/reaction
GA21 (t-NOS)
Cq
IPC (VIC)
Cq
0 copies/reaction
MON89788
(PFMV)
Cq
20,000 copies/reaction
T45 (P35S)
Cq
20,000 copies/reaction
GA21 (t-NOS)
Cq
IPC (Cy5)

Undetermined 23.18 23.27 24.5 Undetermined 24.02 23.41 33.4
Undetermined 22.84 22.94 25.4 Undetermined 23.79 23.2 32.98
Undetermined 22.86 22.94 25.33 Undetermined 23.69 22.95 33.18

Notes and observation

Remaining with the two multiplex methods (method 1 and method 2), in both cases the validation reports provided by the manufacturers did not contain any crosstalk evaluation data. However, our study showed no interference between the different fluorescence detection channels [1], this parameter is evaluated and no crosstalk was observed in the mpPCR avoiding the risk of false positives.

Conclusion

In GMO testing laboratories the screening strategy is a crucial step as it guides and optimises the, far more expensive and cumbersome, event-specific qualitative and quantitative PCR steps that may follow as a result of positivities. Here we presented a preliminary comparative evaluation of three commercial kits, together with the corresponding in-house optimized PCR tests, targeting the three screening elements sought by almost all GMO testing laboratories, namely P35S, T-nos and P-FMV. Although limited to a few screening elements, the application of the ENGL guidelines for the validation and verification of methods in singleplex and multiplex PCR provided data on the performance of such commercial solutions. The results confirm that the kits show high sensitivity, specificity, and practicability showing a substantial equivalence with the singleplex assays currently adopted by the Italian National Reference Laboratory for GM food and feed (NRL). The work done could be useful for all laboratories to evaluate the possibility of introducing commercial diagnostic kits for the screening phase of their workflow for GMO analyses to reduce and optimize workloads.

Limitations

None.

CRediT authorship contribution statement

Daniela Verginelli: Conceptualization, Methodology, Investigation, Writing – original draft, Writing – review & editing. Cinzia Quarchioni: Investigation. Katia Spinella: Visualization, Formal analysis, Writing – review & editing. Davide La Rocca: Visualization, Formal analysis, Writing – review & editing. Pamela Bonini: Investigation. Cristiana Fusco: Investigation. Marisa Misto: Investigation. Stefania Peddis: Investigation. Lorella Peroni: Investigation. Ugo Marchesi: Conceptualization, Writing – review & editing, Supervision.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Footnotes

Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.mex.2024.102878.

Appendix. Supplementary materials

mmc1.docx (2.3MB, docx)
mmc2.docx (23.9KB, docx)

Data Availability

  • Data will be made available on request.

References

  • 1.Gatto F., Savini C., Baillie C.K., Broothaerts W., Burns M., Dagand E., Debode F., Dobnik D., Grohmann L., Lieske K., Marchesi U., Marien A., Mazzara M., Papazova N., Van der Berg J.P., Verginelli D. Publications Office of the European Union; Luxembourg: 2023. Definition of Minimum Performance Requirements for Analytical Methods of GMO Testing part 2. [DOI] [Google Scholar]
  • 2.EU Register of authorised GMOs, European Commission, DG Health and Food Safety. In https://food.ec.europa.eu/plants/genetically-modified-organisms/gmo-register_en
  • 3.ISO 24276:2013 (2013). ISO 24276:2013 — Foodstuffs — Methods of analysis for the detection of genetically modified organisms and derived products — General requirements and definitions. In: @isostandards.
  • 4.ISO 21570:2005. (2005). ISO 21570:2005 — Foodstuffs - Methods of analysis for the detection of genetically modified organisms and derived products - Quantitative nucleic acid based methods. In: @isostandards.
  • 5.ISO 21569:2005 Amd 1:2013 (2005). ISO 21569:2005 — Foodstuffs - Methods of analysis for the detection of genetically modified organisms and derived products - Qualitative nucleic acid based methods. In: @isostandards.
  • 6.ISO 21571:2013 Amd.1-2013 (2013) — Foodstuffs — Methods of analysis for the detection of genetically modified organisms and derived products — Nucleic acid extraction — Amendment 1. In: @isostandards.
  • 7.Holst-Jensen A., Bertheau Y., Alnutt T., Morisset D. Vol. 67297. Luxembourg: Publications Office of the European Union; 2011. p. 58. (Overview On the detection, Interpretation and Reporting On the Presence of Unauthorised Genetically Modified materials: Guidance Document from the European Network of GMO Laboratories (ENGL)). p. [Google Scholar]
  • 8.Berben G., Boniotti B., Loose M., Garavelloni S., Grohmann L., Herau V., Holst-Jensen A., Hubert P., Narendja F., Onori R., Oevsna J., Papazova N., Pecoraro S., Roosens N., Scholtens, I.M.J., Villa D., Welling A., Woll K. and Zel, J. 2017. JRC Technical Reports - Detection, Interpretation and Reporting on the presence of authorised and unauthorised genetically modified materials (Working Group Report).
  • 9.Pauli U., Schouwey B., Hubner P., Brodmann P., Eugster A. Quantitative detection of genetically modified soybean and maize: method evaluation in a Swiss ring trial. Mitt Lebensm Hyg. 2001;92:145–158. [Google Scholar]
  • 10.Gatto F., Paternò A., Ciabatti I., Marchesi U. and Amaddeo D. Report of the collaborative study for the validation of real time PCR methods for GMO screening (2011) https://www.izslt.it/crogm/
  • 11.EU-RL GMFF GMOMETHODS database "Qualitative PCR method for detection of nopaline synthase terminator"; Online Publication (2010); QL-ELE-00-011.
  • 12.EU-RL GMFF GMOMETHODS database “Qualitative PCR method for detection of tE9 terminator”; Online pubblication (2016); QL-ELE-00-024.pdf
  • 13.Weighardt F., Barbati C., Paoletti C., Querci M., Kay S., De Beuckeleer M., Van den Eede G. Real-Time Polymerase Chain Reaction-Based Approach for Quantification of the pat Gene in the T25 Zea mays Event. J. AOAC Int. 2004;87(6):1342–1355. [PubMed] [Google Scholar]
  • 14.Yi C.X., Zhang J., Chan K.M., Liu X.K., Hong Y. Quantitative real-time PCR assay to detect transgene copy number in cotton (Gossypium hirsutum) Anal. Biochem. 2008;375(1):150–152. doi: 10.1016/j.ab.2007.11.022. [DOI] [PubMed] [Google Scholar]
  • 15.Grohmann L., Brunen-Nieweler C., Nemeth A., Waiblinger H.U. Collaborative Trial Validation Studies of Real-Time PCR-Based GMO Screening Methods for Detection of the bar Gene and the ctp2-cp4 epsps Construct. J. Agric. Food Chem. 2009;57:8913–8920. doi: 10.1021/jf901598r. [DOI] [PubMed] [Google Scholar]
  • 16.EU-RL GMFF GMOMETHODS database "Qualitative PCR method for detection of Figwort Mosaic Virus 35S promoter"; Online Publication (2014).; QL-ELE-00-015.
  • 17.Verginelli D., Paternò A., De Marchis M.L., Quarchioni C., Vinciguerra D., Bonini P., Peddis S., Fusco C., Misto M., Marfoglia C., Pomilio F., Marchesi U. Development and comparative study of a pat/bar real-time PCR assay for integrating the screening strategy of a GMO testing laboratory. J. Sci. Food Agric. 2020;100(5):2121–2129. doi: 10.1002/jsfa.10235. Mar 30Epub 2020 Jan 17. PMID: 31875962; PMCID: PMC7384061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.EUginius (EUropean GMO INItiative for a Unified Database System) https://euginius.eu/euginius/pages/home.jsf.
  • 19.Grohmann L., Barbante A., Eriksson R., Gatto F., Georgieva T., Huber I., Hulin J., Köppel R., Marchesi U., Marmin L., Mazzara M., Narendja F., Owen H., Perri E., Scholtens I., Sovová T., Sowa S., Stebih D., Weidner C., Zdeňková K. EUR 30708 EN, Publications Office of the European Union; Luxembourg: 2021. Guidance Document On Multiplex Real-Time PCR Methods. ISBN 978-92-76-37820-4. [DOI] [Google Scholar]
  • 20.Bonfini L. In Silico Proposal of Screening Strategies for Detecting EU Authorised GMOs. European Commission. 2023 Ispra, JRC131782. [Google Scholar]
  • 21.Cottenet G., Blancpain C., Sonnard V., Chuah P.F. Two FAST multiplex real-time PCR reactions to assess the presence of genetically modified organisms in food. Food Chem. 2019;274:760–765. doi: 10.1016/j.foodchem.2018.09.050. Volume. [DOI] [PubMed] [Google Scholar]
  • 22.Huber I., Block A., Sebah D., Debode F., Morisset D., Grohmann L., Berben G., Stebih D., Milavec M., Zel J., Busch U. Development and validation of duplex, triplex, and pentaplex real-time PCR screening assays for the detection of genetically modified organisms in food and feed. J. Agric. Food Chem. 2013;61(43):10293–10301. doi: 10.1021/jf402448y. Oct 30Epub 2013 Oct 18. PMID: 23971699. [DOI] [PubMed] [Google Scholar]
  • 23.Akiyama H., Nakamura F., Yamada C., Nakamura K., Nakajima O., Kawakami H., Harikai N., Furui S., Kitta K., Teshima R. A screening method for the detection of the 35S promoter and the nopaline synthase terminator in genetically modified organisms in a real-time multiplex polymerase chain reaction using high-resolution melting-curve analysis. Biol. Pharm. Bull. 2009;32(11):1824–1829. doi: 10.1248/bpb.32.1824. NovPMID: 19881291. [DOI] [PubMed] [Google Scholar]
  • 24.Woll K., Lieske K., Narendja F., Heissenberger A., Schulze M., Grohmann L., Popping B., Mankertz J. A practical approach to evaluate the equivalence of real-time PCR reagents used as substitute in validated methods. Journal für Verbraucherschutz und Lebensmittelsicherheit. 2013;8:51–56. [Google Scholar]
  • 25.CEN/TS 16707:2014 “Foodstuffs - Methods of analysis for the detection of genetically modified organisms and derived products - Polymerase chain reaction (PCR) based screening strategies”. (2014).
  • 26.Hougs L., Gatto F., Goerlich O., Grohmann L., Lieske K., Mazzara M., Narendja F., Ovesna J., Papazova N., Scholtens I., Žel J. EUR 29015 EN, Publication Office of the European Union; Luxembourg: 2017. Verification of Analytical Methods For GMO Testing When Implementing Interlaboratory Validated Methods. ISBN 978-92-79-77310-5. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

mmc1.docx (2.3MB, docx)
mmc2.docx (23.9KB, docx)

Data Availability Statement

  • Data will be made available on request.


Articles from MethodsX are provided here courtesy of Elsevier

RESOURCES